Approximately 291,088 bottles of Metacam (meloxicam) Oral Suspension, a prescription non-steroidal anti-inflammatory drug (NSAID) for pets, are being recalled because the product strength printed on the inner bottle label does not match the strength listed on the outer display carton. This labeling error affects multiple lots of both the 0.5 mg/mL (15 ml bottles) and 1.5 mg/mL (10 ml bottles) concentrations. Consumers should contact their veterinarian or pharmacist immediately to ensure their pet is receiving the correct dosage. Boehringer Ingelheim Vetmedica Inc. is notifying distributors and customers via letter to facilitate the return of affected products.
The discrepancy between the bottle and the outer packaging could lead to pet owners or veterinarians administering an incorrect dose of meloxicam. Depending on the concentration used, this could result in either an underdose, which fails to manage pain and inflammation, or an overdose, which may cause serious side effects such as gastrointestinal issues or kidney damage.
Drug recall refund/guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response